| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 302,644 | $532,653 | $1.76 | 16 Feb 2026 | Direct |
| LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| Kindred Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | $4.81 | 27 Aug 2021 | Direct | |
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct | ||
| Savara Inc | Director | Stock Option (right to buy) | 0 | 16 Feb 2026 | Direct |